Covidien plc (COV) Expands Device Portfolio for Endovascular Treatment of Peripheral Vascular Disease
9/18/2012 8:51:46 AM
PLYMOUTH, Minn.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of the Viance™ Crossing Catheter and Enteer™ Re-entry System for treating chronic total occlusions (CTOs) endovascularly. The devices are now available in the United States, the European Union (EU) and other select international markets.
comments powered by